GlassScriptPhysician profile
Alison S Spann
NPI 1184867533
$2,099.82
in general payments reported to CMS, 2019-2025
22 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $806 · 2020: $238 · 2021: $403 · 2022: $321 · 2023: $152 · 2024: $60.07 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $570.22 | 2019-2020 | |
| Medtronic, INC. | $301.86 | 2021-2025 | Interstim |
| Allergan, INC. | $243.54 | 2019-2022 | |
| Astellas Pharma US INC | $174.66 | 2019-2022 | |
| Abiomed | $142.70 | 2021 | |
| Janssen Biotech, INC. | $134.53 | 2019-2022 | |
| Coloplast Corp | $133.60 | 2019-2025 | Titan |
| Baxter Healthcare | $75.76 | 2021 | |
| Calyxo, INC. | $47.73 | 2025 | Cvac Aspiration System |
| Pfizer INC. | $36.27 | 2019 | |
| Progenics Pharmaceuticals, INC. | $29.88 | 2022 | |
| Urogen Pharma, INC. | $28.82 | 2022-2023 | Jelmyto |
| Sumitomo Pharma America, INC. | $28.81 | 2023 | Gemtesa |
| Genzyme Corporation | $25.69 | 2022 | |
| Blue Earth Diagnostics | $19.97 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17.82 | 2023 | Upsylon |
| Axonics, INC. | $17.81 | 2023 | Axonics |
| Urovant Sciences INC | $17.57 | 2022 | |
| Endo Pharmaceuticals INC. | $14.76 | 2023 | Aveed, Xiaflex |
| Amniox Medical, INC. | $13.90 | 2019 | |
| Dendreon Pharmaceuticals LLC | $13.00 | 2019 | |
| Ferring Pharmaceuticals INC. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Spann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.